Beiersdorf AG and S-Biomedic NV have announced a research collaboration on skin microbiota. Additionally, Beiersdorf has taken an equity investment in S-Biomedic in the single-digit million euro range.
“Since 1882, Beiersdorf has been successfully building partnerships with suppliers, universities, research institutions, as well as individual inventors and innovators,” said Ralph Gusko, board member, consumer brands at Beiersdorf. “With our investment into S-Biomedic, we open up for cooperations with start-up companies. These pioneers for future technologies will help us deliver answers for unmet consumer needs.”
Added May Shana’a, senior corporate vice president of R&D for Beiersdorf: “Skin care is on the verge of disruption and will hugely benefit from the dramatic progress in life science research. Microbiome research is one of the most dynamic fields, and we need to deeply look at it for innovative offers for our consumers.”
Related: Beiersdorf Announces Plans For New Headquarters and Research Center
